132 related articles for article (PubMed ID: 14512173)
1. Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS.
Killestein J; Eikelenboom MJ; Izeboud T; Kalkers NF; Adèr HJ; Barkhof F; Van Lier RA; Uitdehaag BM; Polman CH
J Neuroimmunol; 2003 Sep; 142(1-2):141-8. PubMed ID: 14512173
[TBL] [Abstract][Full Text] [Related]
2. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease.
Killestein J; Den Drijver BF; Van der Graaff WL; Uitdehaag BM; Polman CH; Van Lier RA
Mult Scler; 2001 Jun; 7(3):145-50. PubMed ID: 11475436
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of co-polymer 1 on cytokine production by CD4 T cells in multiple sclerosis.
Fellay B; Chofflon M; Juillard C; Paunier AM; Landis T; Roth S; Gougeon ML
Immunology; 2001 Dec; 104(4):383-91. PubMed ID: 11899423
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of interferon-β1b on cytokine patterns of CD4+ and CD8+ T cells derived from RRMS and PPMS patients.
Skrzipek S; Vogelgesang A; Bröker BM; Dressel A
Mult Scler; 2012 May; 18(5):674-8. PubMed ID: 22025329
[TBL] [Abstract][Full Text] [Related]
5. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease.
Clerici M; Saresella M; Trabattoni D; Speciale L; Fossati S; Ruzzante S; Cavaretta R; Filippi M; Caputo D; Ferrante P
J Neuroimmunol; 2001 Dec; 121(1-2):88-101. PubMed ID: 11730945
[TBL] [Abstract][Full Text] [Related]
6. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
Hamamcioglu K; Reder AT
Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
[TBL] [Abstract][Full Text] [Related]
7. Cytokine flow cytometry differentiates the clinical status of multiple sclerosis (MS) patients.
Inogés S; Merino J; Bandrés E; De Castro P; Subirá ML; Sánchez-Ibarrola A
Clin Exp Immunol; 1999 Mar; 115(3):521-5. PubMed ID: 10193428
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients.
Nguyen LT; Ramanathan M; Weinstock-Guttman B; Baier M; Brownscheidle C; Jacobs LD
J Neurol Sci; 2003 May; 209(1-2):93-9. PubMed ID: 12686409
[TBL] [Abstract][Full Text] [Related]
9. Differential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns.
Salehi Z; Doosti R; Beheshti M; Janzamin E; Sahraian MA; Izad M
PLoS One; 2016; 11(7):e0159565. PubMed ID: 27467597
[TBL] [Abstract][Full Text] [Related]
10. Interferon-beta treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-gamma and interleukin-4.
Furlan R; Bergami A; Lang R; Brambilla E; Franciotta D; Martinelli V; Comi G; Panina P; Martino G
J Neuroimmunol; 2000 Nov; 111(1-2):86-92. PubMed ID: 11063825
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: chemokine receptor expression on circulating lymphocytes in correlation with radiographic measures of tissue injury.
Fox RJ; Kivisakk P; Fisher E; Tucky B; Lee JC; Rudick RA; Ransohoff RM
Mult Scler; 2008 Sep; 14(8):1036-43. PubMed ID: 18701575
[TBL] [Abstract][Full Text] [Related]
12. Cytokine production from murine CD4 and CD8 cells after mannan-MUC1 immunization.
Lees CJ; Apostolopoulos V; McKenzie IF
J Interferon Cytokine Res; 1999 Dec; 19(12):1373-9. PubMed ID: 10638706
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
[TBL] [Abstract][Full Text] [Related]
14. Analysis of effector CD4 (OX-40+) and CD8 (CD45RA+CD27-) T lymphocytes in active multiple sclerosis.
Hintzen RQ; Pot K; Paty D; Oger J
Acta Neurol Scand; 2000 Jan; 101(1):57-60. PubMed ID: 10660154
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
16. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
[TBL] [Abstract][Full Text] [Related]
17. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.
Soldan SS; Alvarez Retuerto AI; Sicotte NL; Voskuhl RR
J Immunol; 2003 Dec; 171(11):6267-74. PubMed ID: 14634144
[TBL] [Abstract][Full Text] [Related]
18. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
[TBL] [Abstract][Full Text] [Related]
19. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir.
Levacher M; Bouscarat F; Landman R; Chau F; Damond F; Gaudebout C; Mathez D; Leibowitch J; Saimot AG; Sinet M
AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1869-75. PubMed ID: 11118072
[TBL] [Abstract][Full Text] [Related]
20. Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis.
Nakazawa M; Sugi N; Kawaguchi H; Ishii N; Nakajima H; Minami M
J Allergy Clin Immunol; 1997 May; 99(5):673-82. PubMed ID: 9155835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
